The Column Group (TCG) is a venture capital firm specializing in early-stage biotechnology companies, particularly those focused on drug discovery. TCG invests in companies based in the United States, making significant financial and operational commitments to develop unique scientific platforms capable of delivering breakthrough therapeutics. The firm typically participates in Series A through Series E funding rounds, reflecting its long-term approach to company building rather than a quick exit strategy.
Notable portfolio companies include A2 Biotherapeutics, Accent Therapeutics, Arcus Biosciences, and Eikon Therapeutics. TCG's investment philosophy emphasizes deep scientific engagement and long-term value creation. Key partners and decision-makers at TCG bring extensive experience from leading biotech firms and research institutions, ensuring robust support for portfolio companies. Additionally, TCG offers unique value-add services such as strategic guidance, operational support, and access to a network of industry experts to foster the growth and success of their investments.
The Column Group - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Total Investments78
Current Portfolio Count27
Total Portfolio Exits2
Top Investment Stages
Series A25 (34.7%)
Series B23 (31.9%)
Series C15 (20.8%)
Series Unknown5 (6.9%)
Series D4 (5.6%)
Stage Mix
Series A 35%Series B 32%Series C 21%Series Unknown 7%Series D 6%
Concentration shown as share of disclosed investments by stage.
The Column Group - Classification
- Also Known As
- THE Column Group Management LP
- NAICS
- 520000Finance and Insurance
- 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
- 523900Other Financial Investment Activities
- 523990All Other Financial Investment Activities
- 523999Miscellaneous Financial Investment Activities
- SIC
- 6700Holding And Other Investment Offices
- 6790Miscellaneous Investing
- 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
- NAICS
- 525000Funds, Trusts, and Other Financial Vehicles
- 523910Miscellaneous Intermediation
- 523940Portfolio Management and Investment Advice
- SIC
- 6000Depository Institutions
- 6720Investment Offices
- 6722Management Investment Offices, Open-end